![Denis Bedoret](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Denis Bedoret
Directeur Général chez ImCyse SA
Postes actifs de Denis Bedoret
Sociétés | Poste | Début | Fin |
---|---|---|---|
ImCyse SA
![]() ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Directeur/Membre du Conseil | 01/09/2020 | - |
Directeur Général | 01/09/2020 | - | |
Exothera SA
![]() Exothera SA Chemicals: SpecialtyProcess Industries Exothera SA is a Belgian company that manufactures and develops viral vector and nucleic acid. The private company is based in Jumet, Belgium. The company was founded in 2020 by José Fernandez Castillo, Hugues Bultot. The CEO is Thibault Jonckheere. | Directeur/Membre du Conseil | 21/09/2020 | - |
Ncardia Holding SA
![]() Ncardia Holding SA BiotechnologyHealth Technology Ncardia Holding SA provides biotech research and development, business management consulting, technical testing, and administrative services. The private company is based in Mont-Saint-Guibert, Belgium. The Belgian company was founded in 2014. Stefan Braam has been the CEO of the company since 2015. | Directeur/Membre du Conseil | 11/11/2021 | - |
Historique de carrière de Denis Bedoret
Anciens postes connus de Denis Bedoret
Sociétés | Poste | Début | Fin |
---|---|---|---|
ORGENESIS INC. | Corporate Officer/Principal | - | - |
Catalent MSTC, Inc.
![]() Catalent MSTC, Inc. Medical SpecialtiesHealth Technology Catalent MSTC, Inc. provides full service contract development and manufacturing services (CDMO) for cell therapy companies. It offers process and assay development, quality management, and cGMP cell therapy manufacturing services. The company was incorporated on December 27, 2017 and is headquartered in Dover, DE. | President | - | - |
MaSTherCell SA
![]() MaSTherCell SA BiotechnologyHealth Technology MaSTherCell SA engages in providing cell therapy manufacturing services. The company was founded in 2011 and is headquartered in Charleroi, Belgium. | Directeur Administratif | 01/10/2016 | 06/07/2017 |
Directeur Général | 06/07/2017 | - | |
Directeur des opérations | 01/01/2014 | 01/09/2016 |
Formation de Denis Bedoret
University of Liege | Doctorate Degree |
Statistiques
Internationale
Belgique | 6 |
Etats-Unis | 3 |
Opérationnelle
Director/Board Member | 3 |
Chief Executive Officer | 2 |
Chief Administrative Officer | 1 |
Sectorielle
Health Technology | 6 |
Consumer Services | 2 |
Process Industries | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
ORGENESIS INC. | Health Technology |
Entreprise privées | 5 |
---|---|
MaSTherCell SA
![]() MaSTherCell SA BiotechnologyHealth Technology MaSTherCell SA engages in providing cell therapy manufacturing services. The company was founded in 2011 and is headquartered in Charleroi, Belgium. | Health Technology |
Catalent MSTC, Inc.
![]() Catalent MSTC, Inc. Medical SpecialtiesHealth Technology Catalent MSTC, Inc. provides full service contract development and manufacturing services (CDMO) for cell therapy companies. It offers process and assay development, quality management, and cGMP cell therapy manufacturing services. The company was incorporated on December 27, 2017 and is headquartered in Dover, DE. | Health Technology |
ImCyse SA
![]() ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Health Technology |
Exothera SA
![]() Exothera SA Chemicals: SpecialtyProcess Industries Exothera SA is a Belgian company that manufactures and develops viral vector and nucleic acid. The private company is based in Jumet, Belgium. The company was founded in 2020 by José Fernandez Castillo, Hugues Bultot. The CEO is Thibault Jonckheere. | Process Industries |
Ncardia Holding SA
![]() Ncardia Holding SA BiotechnologyHealth Technology Ncardia Holding SA provides biotech research and development, business management consulting, technical testing, and administrative services. The private company is based in Mont-Saint-Guibert, Belgium. The Belgian company was founded in 2014. Stefan Braam has been the CEO of the company since 2015. | Health Technology |
- Bourse
- Insiders
- Denis Bedoret
- Expérience